DHC(DHC)
DHC
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.49B | $1.58B | $1.71B |
| Low | $1.46B | $1.55B | $1.67B |
| High | $1.52B | $1.61B | $1.75B |
| EBITDA Avg | $376M | $399M | $431M |
| Low | $369M | $391M | $422M |
| High | $383M | $406M | $442M |
| EBIT Avg | $94M | $99M | $107M |
| Low | $92M | $97M | $105M |
| High | $96M | $101M | $110M |
| Net Income Avg | $-143M | $-101M | $-88M |
| Low | $-146M | $-103M | $-92M |
| High | $-139M | $-98M | $-88M |
| EPS Avg | $-0.59 | $-0.42 | $-0.38 |
| Low | $-0.61 | $-0.43 | $-0.38 |
| High | $-0.58 | $-0.41 | $-0.37 |
| Analysts (Rev / EPS) | 2 / 2 | 3 / 2 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $375M | $382M | $386M | $392M | $400M | $409M | $427M | $435M |
| Low | $373M | $380M | $384M | $390M | $398M | $407M | $425M | $433M |
| High | $378M | $385M | $389M | $395M | $403M | $412M | $430M | $439M |
| EBITDA Avg | $95M | $96M | $97M | $99M | $101M | $103M | $107M | $110M |
| Low | $94M | $96M | $97M | $98M | $100M | $103M | $107M | $109M |
| High | $95M | $97M | $98M | $99M | $101M | $104M | $108M | $110M |
| EBIT Avg | $24M | $24M | $24M | $25M | $25M | $26M | $27M | $27M |
| Low | $23M | $24M | $24M | $24M | $25M | $26M | $27M | $27M |
| High | $24M | $24M | $24M | $25M | $25M | $26M | $27M | $28M |
| Net Income Avg | $-35M | $-30M | $-30M | $-28M | $-26M | $-21M | — | — |
| Low | $-35M | $-30M | $-31M | $-28M | $-27M | $-21M | — | — |
| High | $-34M | $-29M | $-30M | $-28M | $-26M | $-21M | — | — |
| EPS Avg | $-0.14 | $-0.12 | $-0.13 | $-0.12 | $-0.11 | $-0.09 | — | — |
| Low | $-0.14 | $-0.12 | $-0.13 | $-0.12 | $-0.11 | $-0.09 | — | — |
| High | $-0.14 | $-0.12 | $-0.13 | $-0.12 | $-0.11 | $-0.09 | — | — |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / — | 1 / — |